NEW YORK (GenomeWeb) – Quest Diagnostics reported Q3 revenues today of $1.89 billion, meeting analysts' average revenue estimate, but representing flat revenue growth versus $1.88 billion in Q3 2015 on a reported basis.

Quest's Diagnostic Information Services revenues grew 2 percent compared to a year ago. Volume, measured by the number of requisitions, also grew 2 percent versus the prior year and revenue per requisition was flat.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.